Midazolam
- Product NDC
- 76045-211
- 11-digit product format
- 760450211
- Labeler code
- 76045
- Product ID
- 76045-211_ec9c9aee-b95f-4645-bf17-df7f1e3967d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Midazolam Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA203460
- Marketing category
- ANDA
- Marketing start
- 2021-04-16
- Substance
- MIDAZOLAM HYDROCHLORIDE
- Active strength
- 2 mg/2mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| W7TTW573JJ | MIDAZOLAM HYDROCHLORIDE | 59467-96-8 | MIDAZOLAM HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 76045-211-20 | 76045021120 | 24 BLISTER PACK in 1 CARTON (76045-211-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-211-00) / 2 mL in 1 SYRINGE, GLASS | 24 blister pack | 2021-04-16 | No | No | Historical |